The global malaria diagnostics market size is valued at USD 0.85 billion in 2024 and is projected to reach USD 1.45 billion by 2035, representing a CAGR of 5.0% during the forecast period. As per the World Health Organization (WHO) report, in 2022, nearly 6,08,000 people died due to malaria and 249 million new cases were reported in 2022. Of these, 94% cases were identified in the African region. In order to mitigate the growing concern of malaria, WHO has recommended early parasite-based diagno...

The medical aesthetics market, valued at USD 37.6 billion in 2024, is project to reach USD 40.9 billion in 2025 and USD 102.3 billion by 2035, representing a CAGR of 9.6% during the forecast period 2025 to 2035. Based on the end user, the clinics / medical spas, dermatology centers / cosmetic centers segment holds the largest market share (nearly 50%) in 2025. With respect to gender, females capture the highest share (90%). North America captures majority of the market share. Notably, Asia-Pacif...

The global home healthcare market size is valued at USD 311.66 billion in 2024 and is projected to reach USD 719.31 billion by 2035, representing a CAGR of 7.90% during the forecast period. North America currently accounts for the highest share (51%) of the market. Currently, services occupy an 85% share of the market with products accounting for the rest. The global market for home healthcare will also be propelled by increasing patient preferences for remote care and technological advancements...

The global rehabilitation robots market size is estimated to grow from USD 0.29 billion in 2024 to USD 1.33 billion by 2035, representing a CAGR of 15% during the forecast period. In 2024, the World Health Organization reported that more than 15 million people are living with spinal cord injuries and the majority of these causes are due to accidental falls, road accidents and trauma. This rising incidence of spinal cord injuries has underscored the demand for rehabilitation robots, specifically...

The smart inhalers market size is valued at USD 1.53 billion in 2024 and is expected to reach USD 5.84 billion by 2035, representing a CAGR of 12.95% during the forecast period 2024-2035. According to our projection, currently hospital pharmacies occupy the highest share (nearly 45%) of the market owing to flexibility, convenience and comfort of purchasing smart inhalers in the healthcare settings for hospitalized patients. Furthermore, there is an increase in the number of hospitalized patients...

The global drug delivery technologies market is currently valued at $0.52 billion and is poised to reach $6.42 billion by 2035, at a CAGR of 25.5%, during the forecast period. Given the inherent requirement for frequent medication, patients suffering from such long-lasting clinical conditions generally end up spending high amounts on not only the prescribed therapeutic regimen, but also on numerous hospital visits for dose administration. Since 2018, more than 250 biologics (including antibody d...

The global surgical sutures market is estimated to grow from $4.79 billion in 2024 to $8.70 billion by 2035, at a steady CAGR of 5.57% during the forecast period. In September 2024, Meril announced the launch of New Edge suture that has enhanced durability, precision and reliability and minimizes the risk of complication and re-surgery. Further, in October 2024, Globus Medical announced the launch of TENSOR

Orthokeratology is defined as the use of custom designed (as per the patient

According to the National Health Council, nearly 40% of the adult population in the US is diagnosed with at least one chronic condition, such as diabetes, asthma, and hypertension. The annual cost burden associated with chronic diseases in the US is around USD 3.8 trillion. This has prompted stakeholders to develop devices that enable self-administration of drugs. Amongst the various self-injection devices, autoinjectors have steadily gained prominence, especially for the treatment of emergency...

The 4D bioprinting market, valued at USD 31 million in 2025, is projected to grow to USD 40 million in 2026 and USD 684 million by 2035, representing a CAGR of 37.2% during the forecast period. Owing to the ongoing advancements in the 4D bio fabrication technology, several players are actively adopting and developing 4D bioprinters and smart biomaterials. It is worth highlighting that 4D bioprinting is garnering a lot of attention from academicians and industry players. In fact, the volume of af...

The at home testing kits market, valued at USD 18.21 billion in 2025, is projected to grow to USD 19.24 billion in 2026 and USD 31.15 billion by 2035, representing a CAGR of 5.5% during the forecast period. Since the approval of the first over-the-counter test kits in early 1976, there has been a substantial increase in the development initiatives focused on such products. In this context, it is worth highlighting that over 20 million at-home pregnancy test kits are being annually sold in the US...

The global handheld ultrasound scanners market is estimated to grow from USD 583 million in 2024 to USD 1,142 million by 2030, representing a CAGR of 12% during the forecast period. Point-of-care ultrasound or handheld ultrasound imaging devices emerged as a viable solution to empower clinicians with portable, mobile, and lightweight scanners for disease diagnosis. For instance, Butterfly IQ (an innovative handheld ultrasound scanner) is available at only 2% of the cost of a conventional ultraso...

The drug device combination products market, valued at USD 327 million in 2025, is projected to grow to USD 357 million in 2026 and USD 938 million by 2035, representing a CAGR of 11.3% during the forecast period. Combination products comprise of two or more FDA- regulated components that provide controlled release of the APIs. However, the development of drug-device combination products is a long-drawn-out process that not only requires novel technologies and processes but also a huge amount of...

The global safety syringe and safety needles market, valued at USD 6.80 billion in 2025, is projected to reach USD 6.90 billion in 2026 and USD 8.90 billion by 2035, representing a CAGR of 2.9% during the forecast period. Given the increasing incidence of needlestick injury among patients, there is a surge in the requirement of safety syringes and needles. Safety needles refer to syringes that are specifically designed to reduce the risk of needlestick injuries and enhance safety to prevent the...

The global container closure integrity testing market size is estimated to be worth USD 252 million in 2025 and is expected to reach USD 269 million in 2026 and USD 558 million by 2035 at a CAGR of 8.4% during the forecast period. The market for container closure integrity testing (CCIT) is anticipated to witness outstanding growth over this projection time frame. Majorly, continuous advancement in testing methods can be attributed to elevating the market growth. With more than 40 service provi...

The global pharmaceutical vials market, valued at USD 11.65 billion in 2025, is projected to reach USD 12.33 billion in 2026 and USD 15.85 billion by 2030, with a 6.5% CAGR during the forecast period, 2026 to 2030. Pre-sterilized / ready-to-use (RTU) pharmaceutical vials have emerged as a promising alternative to conventional pharmaceutical vials, adding significant value to streamline pharmaceutical fill / finish operations. It is worth noting that these innovations have significantly helped in...

The ocular drug delivery devices market is expected to grow from USD 964 Mn in 2025 to USD 1,098 Mn in 2026 and USD 1,616 Mn by 2030, at a CAGR of 10.1%. It is also worth highlighting that around 1.7 billion individuals worldwide are expected to lose their vision by 2050. As per the Centers for Disease Control and Prevention (CDC), loss of vision can pose an economic burden of over USD 35 billion, in terms of loss of productivity and direct costs of treatment / care. In fact, over 1,100 patents...

Chronic diseases, such as diabetes, arthritis, hypertension and cancer, are considered among the leading causes of death, worldwide. Lack of adherence to prescribed medication regimens (due to various reasons) and high cost of treatment (a significant share of which stems from non-compliance to treatment), are the major contributing factors to the associated burden on patients and the healthcare system. However, modern therapy administration technology, such as wearable and implantable drug deli...

The medical batteries market, valued at USD 1.64 billion in 2025, is projected to grow to USD 1.85 billion in 2026 and USD 3.10 billion by 2030, representing a CAGR of 13.8% during the forecast period. The exponential growth in wearable medical devices and implants, such as hearing aids, implantable cardiac defibrillators, infusion pumps, neurostimulators and pacemakers, has led to an increase in demand for safe, compact, lightweight and high energy density batteries with better cycle life. Desp...

The portable x ray devices market is estimated to be worth $900 million in 2021 and is expected to grow at CAGR of 13% during the forecast period. Since the discovery of X-rays, the field of medical imaging has evolved significantly, offering a non-invasive means for physicians to accurately visualize almost all major organ systems for diagnostic purposes. Presently, there are a number of handheld X-ray imaging devices available in the market, and several device developers are engaged in efforts...